Literature DB >> 8328779

Inactivation of rifampin by Nocardia brasiliensis.

K Yazawa1, Y Mikami, A Maeda, M Akao, N Morisaki, S Iwasaki.   

Abstract

Rifampin was glycosylated by a pathogenic species of Nocardia, i.e., Nocardia brasiliensis. The structures of two glycosylated compounds (RIP-1 and RIP-2) isolated from the culture broth of the bacterium were determined to be 3-formyl-23-(O-[beta-D-glucopyranosyl])rifamycin SV and 23-(O-[beta-D-glucopyranosyl])rifampin, respectively. Both compounds lacked antimicrobial activity against other gram-positive bacteria as well as the Nocardia species.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8328779      PMCID： PMC187958          DOI： 10.1128/AAC.37.6.1313

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  17 in total

1.  Microbial glycosylation of erythromycin A.

Authors:  M S Kuo; D G Chirby; A D Argoudelis; J I Cialdella; J H Coats; V P Marshall
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191

2.  Rifamycins: an insight into biological activity based on structural investigations.

Authors:  M Brufani; S Cerrini; W Fedeli; A Vaciago
Journal:  J Mol Biol       Date:  1974-08-15       Impact factor: 5.469

3.  [Coordination of the 13C-NMR. spectrum of rifamycin S on the basis of selective uncoupling of protons].

Authors:  H Fuhrer
Journal:  Helv Chim Acta       Date:  1973-07       Impact factor: 2.164

4.  Alteration of ribosomes and RNA polymerase in drug-resistant clinical isolates of Mycobacterium tuberculosis.

Authors:  T Yamada; A Nagata; Y Ono; Y Suzuki; T Yamanouchi
Journal:  Antimicrob Agents Chemother       Date:  1985-06       Impact factor: 5.191

5.  Correlation of structure and activity in ansamycins: molecular structure of cyclized rifamycin SV.

Authors:  S K Arora; P Main
Journal:  J Antibiot (Tokyo)       Date:  1984-02       Impact factor: 2.649

6.  Rifampicin: a new orally active rifamycin.

Authors:  N Maggi; C R Pasqualucci; R Ballotta; P Sensi
Journal:  Chemotherapy       Date:  1966       Impact factor: 2.544

7.  Mutation to rifampicin resistance at the beginning of the RNA polymerase beta subunit gene in Escherichia coli.

Authors:  N A Lisitsyn; E D Sverdlov; E P Moiseyeva; O N Danilevskaya; V G Nikiforov
Journal:  Mol Gen Genet       Date:  1984

8.  Aminoglycoside antibiotic-inactivating enzymes in actinomycetes similar to those present in clinical isolates of antibiotic-resistant bacteria.

Authors:  R Benveniste; J Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1973-08       Impact factor: 11.205

9.  In-vitro activity of new carbapenem antibiotics: comparative studies with meropenem, L-627 and imipenem against pathogenic Nocardia spp.

Authors:  K Yazawa; Y Mikami; S Ohashi; M Miyaji; Y Ichihara; C Nishimura
Journal:  J Antimicrob Chemother       Date:  1992-02       Impact factor: 5.790

10.  Biosynthetic studies on saframycin A, a quinone antitumor antibiotic produced by Streptomyces lavendulae.

Authors:  Y Mikami; K Takahashi; K Yazawa; T Arai; M Namikoshi; S Iwasaki; S Okuda
Journal:  J Biol Chem       Date:  1985-01-10       Impact factor: 5.157
View more
  15 in total

1.  ADP-ribosylation as an intermediate step in inactivation of rifampin by a mycobacterial gene.

Authors:  S Quan; T Imai; Y Mikami; K Yazawa; E R Dabbs; N Morisaki; S Iwasaki; Y Hashimoto; K Furihata
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

2.  Monooxygenase-like sequence of a Rhodococcus equi gene conferring increased resistance to rifampin by inactivating this antibiotic.

Authors:  S J Andersen; S Quan; B Gowan; E R Dabbs
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

3.  Characterization of a rifampin-inactivating glycosyltransferase from a screen of environmental actinomycetes.

Authors:  Peter Spanogiannopoulos; Maulik Thaker; Kalinka Koteva; Nicholas Waglechner; Gerard D Wright
Journal:  Antimicrob Agents Chemother       Date:  2012-07-16       Impact factor: 5.191

4.  Molecular basis of rifampin resistance in Streptococcus pneumoniae.

Authors:  T Padayachee; K P Klugman
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

5.  Ribosylative inactivation of rifampin by Mycobacterium smegmatis is a principal contributor to its low susceptibility to this antibiotic.

Authors:  S Quan; H Venter; E R Dabbs
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

6.  Arr-cb Is a Rifampin Resistance Determinant Found Active or Cryptic in Clostridium bolteae Strains.

Authors:  Jean-Christophe Marvaud; Thierry Lambert
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

7.  Contribution of rpoB2 RNA polymerase beta subunit gene to rifampin resistance in Nocardia species.

Authors:  Jun Ishikawa; Kazuhiro Chiba; Haruyo Kurita; Hiroyuki Satoh
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

8.  Ribosylation by mycobacterial strains as a new mechanism of rifampin inactivation.

Authors:  E R Dabbs; K Yazawa; Y Mikami; M Miyaji; N Morisaki; S Iwasaki; K Furihata
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

9.  Sequence and analysis of the rpoB gene of Mycobacterium smegmatis.

Authors:  S V Hetherington; A S Watson; C C Patrick
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

10.  The Structure of the Antibiotic Deactivating, N-hydroxylating Rifampicin Monooxygenase.

Authors:  Li-Kai Liu; Heba Abdelwahab; Julia S Martin Del Campo; Ritcha Mehra-Chaudhary; Pablo Sobrado; John J Tanner
Journal:  J Biol Chem       Date:  2016-08-24       Impact factor: 5.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.